Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A from the PICASSO Trial

Background and purpose Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage...

Descripción completa

Detalles Bibliográficos

Autores principales:	Eun-Jae Lee, Sun U. Kwon, Jong-Ho Park, Yong-Jae Kim, Keun-Sik Hong, Sungwook Yu, Yang-Ha Hwang, Ji Sung Lee, Juneyoung Lee, Joung-Ho Rha, Sung Hyuk Heo, Sung Hwan Ahn, Woo-Keun Seo, Jong-Moo Park, Ju-Hun Lee, Jee-Hyun Kwon, Sung-Il Sohn, Jin-Man Jung, Hahn Young Kim, Eung-Gyu Kim, Sung Hun Kim, Jae-Kwan Cha, Man-Seok Park, Hyo Suk Nam, Dong-Wha Kang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Korean Stroke Society 2020-01-01
Colección:	Journal of Stroke
Materias:	cholesterol, hdl secondary prevention cilostazol probucol cholesterol ester transfer proteins
Acceso en línea:	http://www.j-stroke.org/upload/pdf/jos-2019-02551.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!